Technical / White Paper

Discover the benefits of C3 Reduct®, Sabinsa’s new curcuminoid innovation!

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by Sabinsa Europe, and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

Discover the benefits of C3 Reduct®, Sabinsa’s new curcuminoid innovation!

Sabinsa’s C3 Reduct®​ is the only reductive metabolites of curcuminoids on the market to be approved as a Novel Food by EFSA. Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct®​ has been shown to boost organ health and sports nutrition, and deliver a range of other targeted functionalities. Find out for yourself how C3 Reduct®​ can help you meet consumer health and wellness expectations – and  open up new market opportunities. 

Related resources from Sabinsa Europe

Supplier info centre